Good News for the 80 Million Korean in the World. Greeting from www.drleepediatrics.com.세계 8천만 한국인에게 좋은 소식입니다. www.drleepediatrics.com 인사말 You are welcome to visit www.drleepediatrics.com. This website is one of the most useful pediatric websites, written into Korean, for the … Continued
부모도 반의사가 되어야 한다–소아가정간호백과 www.drleepediatrics.com 웹소아과를 내 놓으면서. Parents must also become anti-doctors – Pediatric Home Nursing Encyclopedia www.drleepediatrics.com Launching a web pediatric clinic 과거 7년 동안 전 세계 8천만 한인들에게 무료로 공개 했던 ‘부모도 반의사가 되어야 한다 (소아가정간호백과) … Continued
Good News for the 80 Million Koreans in the World The Greeting from www.drleepediatrics.com . www.drleepediatrics.com 인사말 You are welcome to visit www.drleepediatrics.com. This website is one of the most useful pediatric websites, written into Korean, for the eighty million … Continued
미국 플로리다 주 학생자녀들이 학교 성적표를 부모들에게 가지고 온 후 몇일 동안 육체적 학대를 받는 아이들의 수가 보통 때 보다 3배가 넘는다고 한다. 소스” NEJM Journal Watch 2/2019. It is said that the number of students in Florida, USA, who … Continued
꿀로 상기도 감염을 치료하면 기침 등 증상이 덜 해 진다고 한다. 소스: NEJM Journal Watch 10/2020. 꿀로 상기도 감염을 치료하면 기침 등 증상이 덜 해 진다고 한다. 소스: NEJM Journal Watch 10/2020/ It is said that treating upper respiratory infections … Continued
Children with acute diarrhea receiving 5 mg or 10 mg per day of supplemental zinc had diarrhea outcomes similar to those in children receiving 20 mg but had less vomiting.소스:10/2020 Gastro, NEJM.org. 하루에 5mg 또는 10mg의 아연 보충을 받은 급성 … Continued
활성 루푸스 신장염(Active lupus nephritis)을 표준 치료에다 belimumab을 첨가해 치료 하면 치료효과가 월씬 좋다고 한다. In this trial involving patients with active lupus nephritis, more patients who received belimumab plus standard therapy had a primary efficacy renal response than … Continued
Belimumab as Add-on Therapy in Lupus Nephritis. 루푸스 신염에 대한 추가 요법으로서의 벨리무맙 Most patients have an initial response, but relapses are common, and treatment-resistant disease often occurs. Although long-term outcomes have improved since the 1980s
chronic spontaneous urticaria treatment with Benralizumab. Benralizumab을 이용한 만성 자발성 두드러기 치료 Benralizumab, an anti–interleukin-5-receptor antibody, was evaluated in a 24-week study involving 12 patients with chronic spontaneous urticaria. The disease was assessed on the basis of urticaria activity … Continued